HighTower Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5,627
| Closed | -$290K | – | 3319 |
|
|
2022
Q2 | $290K | Sell |
5,627
-5,209
| -48% | -$270K | ﹤0.01% | 2386 |
|
|
2022
Q1 | $800K | Buy |
10,836
+2,486
| +30% | +$222K | ﹤0.01% | 1887 |
|
|
2021
Q4 | $1.19M | Buy |
8,350
+3,393
| +68% | +$583K | ﹤0.01% | 1675 |
|
|
2021
Q3 | $1.02M | Buy |
4,957
+1,987
| +67% | +$438K | ﹤0.01% | 1640 |
|
|
2021
Q2 | $629K | Buy |
2,970
+970
| +49% | +$178K | ﹤0.01% | 1918 |
|
|
2021
Q1 | $365K | Sell |
2,000
-204
| -9% | -$40.7K | ﹤0.01% | 2162 |
|
|
2020
Q4 | $245K | Buy |
+2,204
| New | +$234K | ﹤0.01% | 2070 |
|
|
2020
Q3 | – | Sell |
-2,583
| Closed | -$214K | – | 2641 |
|
|
2020
Q2 | $214K | Buy |
+2,583
| New | +$98.8K | ﹤0.01% | 1952 |
|
|
2019
Q2 | – | Sell |
-1,749
| Closed | -$21K | – | 2471 |
|
|
2019
Q1 | $21K | Sell |
1,749
-610
| -26% | -$19.3K | ﹤0.01% | 2177 |
|
|
2018
Q4 | $87K | Sell |
2,359
-185
| -7% | -$7.17K | ﹤0.01% | 1976 |
|
|
2018
Q3 | $98K | Sell |
2,544
-893
| -26% | -$25.1K | ﹤0.01% | 2057 |
|
|
2018
Q2 | $92K | Sell |
3,437
-648
| -16% | -$21.9K | ﹤0.01% | 2012 |
|
|
2018
Q1 | $171K | Sell |
4,085
-1,405
| -26% | -$56.4K | ﹤0.01% | 1905 |
|
|
2017
Q4 | $129K | Sell |
5,490
-1,196
| -18% | -$29.2K | ﹤0.01% | 1996 |
|
|
2017
Q3 | $150K | Buy |
6,686
+1
| +0% | +$22 | ﹤0.01% | 1955 |
|
|
2017
Q2 | $149K | Sell |
6,685
-415
| -6% | -$8.14K | ﹤0.01% | 1892 |
|
|
2017
Q1 | $184K | Buy |
7,100
+262
| +4% | +$7.21K | ﹤0.01% | 1787 |
|
|
2016
Q4 | $176K | Sell |
6,838
-937
| -12% | -$27.3K | ﹤0.01% | 1699 |
|
|
2016
Q3 | $316K | Buy |
7,775
+1,477
| +23% | +$191K | ﹤0.01% | 1430 |
|
|
2016
Q2 | $918K | Buy |
6,298
+284
| +5% | +$32.5K | 0.01% | 921 |
|
|
2016
Q1 | $614K | Buy |
6,014
+290
| +5% | +$31.1K | ﹤0.01% | 1272 |
|
|
2015
Q4 | $956K | Buy |
5,724
+1,205
| +27% | +$185K | 0.01% | 992 |
|
|
2015
Q3 | $639K | Buy |
4,519
+735
| +19% | +$165K | 0.01% | 1098 |
|
|
2015
Q2 | $843K | Buy |
3,784
+341
| +10% | +$59.9K | 0.01% | 836 |
|
|
2015
Q1 | $569K | Buy |
3,443
+9
| +0.3% | +$1.46K | 0.01% | 1027 |
|
|
2014
Q4 | $407K | Sell |
3,434
-91
| -3% | -$9.51K | 0.01% | 1122 |
|
|
2014
Q3 | $294K | Buy |
3,525
+425
| +14% | +$38.4K | 0.01% | 1216 |
|
|
2014
Q2 | $286K | Sell |
3,100
-4,211
| -58% | -$370K | 0.01% | 1274 |
|
|
2014
Q1 | $662K | Sell |
7,311
-526
| -7% | -$58.8K | 0.01% | 885 |
|
|
2013
Q4 | $803K | Buy |
7,837
+2,270
| +41% | +$160K | 0.02% | 783 |
|
|
2013
Q3 | $393K | Buy |
5,567
+4,237
| +319% | +$239K | 0.01% | 936 |
|
|
2013
Q2 | $55K | Buy |
+1,330
| New | +$57.6K | ﹤0.01% | 1209 |
|
Other funds holding NVAX
CS
HighTower Advisors's NVAX Position: Q3 2022 in Review
HighTower Advisors sold out of Novavax (NVAX) in Q3 2022, closing a stake of 5,627 shares — an estimated $290K sold.
HighTower Advisors first reported a position in NVAX in Q2 2013 and held it in 32 quarters. The position peaked at $1.19M in Q4 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.
- HighTower Advisors reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
- HighTower Advisors sold 5,627 Novavax shares in Q3 2022, an estimated $290K.
- HighTower Advisors first reported a position in Novavax in Q2 2013 and held it in 32 quarters.
- HighTower Advisors's Novavax position peaked at $1.19M in Q4 2021.
- 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.
Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.